Diabetes mellitus and bone metabolism

Area of Science:

• Endocrinology
• Metabolic Diseases
• Bone Biology

Background:

• The existence of diabetic osteopathy remains uncertain, with conflicting epidemiological data on bone mass and fracture risk in diabetes mellitus.
• Type I diabetes involves immune phenomena and potential inflammation-mediated osteopenia (IMO), possibly affecting peak bone mass.
• Type II diabetes, often associated with obesity, presents factors that may protect against bone loss, such as increased adipose tissue and insulin-related growth factors.

Purpose of the Study:

• To investigate the complex relationship between diabetes mellitus and bone health, exploring both detrimental and potentially protective effects.
• To reconcile discrepant findings in epidemiological studies regarding bone mass and fracture incidence in diabetic populations.
• To explore potential therapeutic insights from type II diabetes for managing osteoporosis in non-diabetic individuals.

Main Methods:

• Review and synthesis of existing epidemiological studies on diabetes mellitus and bone health.
• Analysis of factors influencing bone metabolism in type I and type II diabetes, including inflammation, growth factors, and hormonal changes.
• Consideration of diabetic complications and their independent effects on fracture risk.

Main Results:

• Epidemiological studies present conflicting results on bone mass in diabetics, with some showing diminished bone mass and others unchanged or even positive trends.
• Increased osteoporotic fractures have been observed in some diabetic cohorts, but no general trends for fracturing bones were consistently found.
• Type I diabetes may be associated with bone loss due to inflammation and hormonal factors, while type II diabetes might exhibit bone-protective effects potentially linked to metabolic and hormonal profiles.

Conclusions:

• The impact of diabetes mellitus on bone health is multifaceted, with type I and type II diabetes exhibiting distinct effects.
• Diabetic complications can independently influence fracture risk, irrespective of bone mineral density.
• Positive bone effects observed in type II diabetes warrant further research for potential applications in treating osteoporosis in the general population.